rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1990-5-25
|
pubmed:abstractText |
Lipoproteid-X was revealed at the onset of the disease in 59.6% of patients with acute viral hepatitis with prevalence of the cholestasis syndrome and cytolysis. Lipoproteid-X may be revealed in moderate activity of alkaline phosphatase. Lipoproteid-X was revealed in 66.7% of patients with chronic cholestatic hepatitis and biliary cirrhosis independent of the duration of the pathological process.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0049-6804
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
116-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2330694-Acute Disease,
pubmed-meshheading:2330694-Adult,
pubmed-meshheading:2330694-Aged,
pubmed-meshheading:2330694-Cholestasis,
pubmed-meshheading:2330694-Chronic Disease,
pubmed-meshheading:2330694-Diagnosis, Differential,
pubmed-meshheading:2330694-Electrophoresis, Agar Gel,
pubmed-meshheading:2330694-Female,
pubmed-meshheading:2330694-Hepatitis A,
pubmed-meshheading:2330694-Hepatitis B,
pubmed-meshheading:2330694-Humans,
pubmed-meshheading:2330694-Lipoprotein-X,
pubmed-meshheading:2330694-Liver Cirrhosis, Biliary,
pubmed-meshheading:2330694-Middle Aged
|
pubmed:year |
1990
|
pubmed:articleTitle |
[The diagnostic significance of lipoprotein-X].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|